The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Drug Manufacturers - Specialty & Generic industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
79 of 153
P/E 20.6 vs period average 18.0 Richer than its history
Ranked among 25 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/25 | ![]() | $10.03 | 11.9 | 84 | 73 | 97 | 99 |
| 2/25 | ![]() | $25.02 | 69.5 | 75 | 72 | 89 | 97 |
| 3/25 | ![]() | $78.25 | 16.9 | 86 | 97 | 71 | 93 |
| 4/25 | ![]() | $4.32 | 5.5 | 95 | 73 | 53 | 93 |
| 5/25 | ![]() | $34.29 | 14.7 | 83 | 93 | 78 | 92 |
| 6/25 | ![]() | $100.95 | 23.9 | 29 | 51 | 91 | 91 |
| 7/25 | ![]() | $6.25 | — | 97 | 27 | 83 | 83 |
| 8/25 | ![]() | $29.47 | 23.4 | 90 | 80 | 96 | 83 |
| 9/25 | ![]() | $22.12 | — | 34 | 43 | 68 | 80 |
| 10/25 | ![]() | $38.82 | 13.8 | 65 | 68 | 68 | 76 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $9B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $20B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.4% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks